Compare TNYA & PED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TNYA | PED |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 168.2M | 152.8M |
| IPO Year | 2021 | 2012 |
| Metric | TNYA | PED |
|---|---|---|
| Price | $0.69 | $13.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $5.33 | ★ $30.00 |
| AVG Volume (30 Days) | ★ 2.0M | 18.4K |
| Earning Date | 05-07-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.96 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $45,751,000.00 |
| Revenue This Year | N/A | $171.75 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 15.67 |
| 52 Week Low | $0.53 | $0.43 |
| 52 Week High | $2.35 | $18.89 |
| Indicator | TNYA | PED |
|---|---|---|
| Relative Strength Index (RSI) | 41.07 | 59.87 |
| Support Level | $0.65 | $12.89 |
| Resistance Level | $0.81 | $13.92 |
| Average True Range (ATR) | 0.03 | 0.69 |
| MACD | -0.00 | 0.21 |
| Stochastic Oscillator | 26.13 | 83.28 |
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties with a long production history, well-defined geology, and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming, the Powder River Basin (PRB) in Wyoming, and the San Andres formation of the Permian Basin situated in West Texas and eastern New Mexico (the Permian Basin).